![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0142|120|2|229-237
ISSN: 0008-543x
Source: CANCER, Vol.120, Iss.2, 2014-01, pp. : 229-237
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract